THE MYELOID U937 SKIN SENSITIZATION TEST (MUSST) FOR THE PREDICTION OF SKIN SENSITIZATION POTENTIAL
2011
| L'Oreal
A mechanistic rationale for the prediction of skin irritancy effects implemented in a workflow process
2011
| L'Oreal
PERMEABILITY COEFFICIENT MEASUREMENT
2010
| L'Oréal
Assessment of the Effects of Pre-Incubation Time on Irritation Potential Using the EpiSkin® in vitro Irritation Test
2010
| Charles River
Expression profiles of phases 1 and 2 metabolizing enzymes in human skin and the reconstructed skin models EpiskinTM and full thickness model from EpiskinTM
2009
Elsevier Journal of Steroid Biochemistry and Molecular Biology | L'Oréal, Episkin, SkinEthic
PROMISING ALTERNATIVE METHOD FOR SKIN PENETRATION EVALUATION USING RECONSTRUCTED EPIDERMIS MODEL
2009
| L'Oreal, Episkin, SkinEthic
Expression profiles of phases 1 and 2 metabolizing enzymes in human skin and the reconstructed skin models Episkin and full thickness model from Episkin.
2009
J Steroid Biochem Mol Biol. 2009 Sep;116(3-5):178-86 | L'Oréal, Research & Innovation
The use of reconstructed human epidermis for skin absorption testing: Results of the validation study.
2008
|
Prediction of chemical absorption into and through the skin
2008
British Journal of Dermatology | L'Oreal, Episkin, SkinEthic
The episkin phototoxicity assay (EPA): Development of an in vitro tiered strategy using 17 reference chemicals to predict phototoxic potency
2007
Toxicol In vitro, 2007 Sep;21(6):977-995 | L'Oreal Research, Life Sciences, 1 Av. E. Schueller,93600 Aulnay-sous-Bois
The ECVAM international validation study on in vitro tests for acute skin irritation: report on the validity of the EPISKIN and EpiDerm assays and on the Skin Integrity Function Test.
2007
| Episkin
The ECVAM International Validation Study on In VitroTests for Acute Skin Irritation: Selection of Test Chemicals
2007
| Episkin
Development of genotoxicity test procedures with Episkin®, a reconstructed human skin model: Towards new tools for in vitro risk assessment of dermally applied compounds?
2006
Mutation Research/Genetic Toxicology and Environmental Mutagenesis Volume 606, Issues 1-2, 14 July 2006, Pages 39-51 | L’Oréal, Advanced Research, Life Sciences, Safety Research Department, Phototoxicity-Genotoxicity-Carcinogenicity Group, 1, avenue E. Schueller, F-93600 Aulnay Sous Bois, France
Gene expression profiles of three different models of reconstructed human epidermis and classical cultures of keratinocytes using cDNA arrays
2004
Arch Dermatol Res Date: Aug 25 2004 ; | L'Oreal, Centre Charles Zviak, 90 rue du General Roguet, 92583, Clichy Cedex, France.
The validation of in vitro methods for skin irritation
2004
Toxicol Lett 2004 ;149 (1-3):387-90 | Syngenta Central Toxicology Laboratory, Alderley Park, Macclesfield SK10 4TJ, UK. [email protected]
Iron chelation can modulate UVA-induced lipid peroxidation and ferritin expression in human reconstructed epidermis
2004
Photodermatol Photoimmunol Photomed 2004 Feb ;20 (1):47-52 | L'Oreal Recherche, Clichy, France. [email protected]
Comparison of cutaneous bioavailability of cosmetic preparations containing caffeine or < alpha >-tocopherol applied on human skin models or human skin ex vivo at finite doses
2002
SKIN PHARMACOL APPL SKIN PHYSIOL. Skin Pharmacology and Applied Skin Physiology 2002 ;15 (Suppl. 1):40-58 | F. Dreher, L'Oreal Research, F-93601 Aulnay-sous-Bois EML: [email protected]
Improvement of the experimental setup to assess cutaneous bioavailability on human skin models: dynamic protocol
2002
Skin Pharmacol Appl Skin Physiol 2002 ;15 Suppl 1):31-9 | L'Oreal Research, Aulnay-sous-Bois, France. [email protected]
Predictive ability of reconstructed human epidermis equivalents for the assessment of skin irritation of cosmetics
2002
Toxicol In Vitro 2002 ;16 (5):557-72 | Cosmital SA (Research Company of Wella AG, Germany), Rte de Chesalles 21, CH-1723 Marly, Switzerland. [email protected]
Reconstructed skin kits: reproducibility of cutaneous irritancy testing
2002
Skin Pharmacol Appl Skin Physiol 2002 ;15 Suppl 1):74-91 | Cosmital SA (Research Company of Wella AG, Germany), Marly, Switzerland. [email protected]